Fmr LLC Journey Medical Corp Transaction History

Fmr LLC

$1.81 Trillion
Q3 2025

A detailed history of Fmr LLC transactions in Journey Medical Corp stock. As of the latest transaction made, Fmr LLC holds 19 shares of DERM stock, worth $150. This represents 0.0% of its overall portfolio holdings.

Number of Shares

Holding current value

$150

% of portfolio

0.0%

3 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Nov 13, 2025	BUY	$6.9 - $8.54 $131 - $162	19 New	19 $0
Q1 2025 May 12, 2025	BUY	$3.66 - $6.54 $7 - $13	2 New	2 $0
Q4 2023 Feb 13, 2024	BUY	$2.7 - $7.96 $345 - $1,018	128 New	128 $0

Others Institutions Holding DERM

# of Institutions

Shares Held

8.96M

Call Options Held

Put Options Held

Tang Capital Management LLC San Diego, CA

1.85M
Shares

$14.7 Million
0.6% of portfolio
Wasatch Advisors Inc Salt Lake City, UT

1.31M
Shares

$10.4 Million
0.05% of portfolio
Opaleye Management Inc. Boston, MA

971K
Shares

$7.71 Million
1.15% of portfolio
B. Riley Securities, Inc. Los Angeles, CA

865K
Shares

$6.87 Million
0.36% of portfolio
Vanguard Group Inc Valley Forge, PA

615K
Shares

$4.88 Million
0.0% of portfolio

View Full List

About Journey Medical Corp

Ticker DERM
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 11,596,500
Market Cap $92.1M
Description
Journey Medical Corporation focuses on the development and commercialization of pharmaceutical products for the treatment of dermatological conditions in the United States. The company's marketed products include Qbrexza, a medicated cloth towelette for the treatment of primary axillary hyperhidrosis; Accutane, an oral isotretinoin drug to treat...

More about DERM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.

Account